CN113816875A - Material monomer and preparation method and application thereof - Google Patents
Material monomer and preparation method and application thereof Download PDFInfo
- Publication number
- CN113816875A CN113816875A CN202111245015.0A CN202111245015A CN113816875A CN 113816875 A CN113816875 A CN 113816875A CN 202111245015 A CN202111245015 A CN 202111245015A CN 113816875 A CN113816875 A CN 113816875A
- Authority
- CN
- China
- Prior art keywords
- material monomer
- adhesive
- composition
- monomer
- cyanoacrylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 60
- 239000000178 monomer Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000853 adhesive Substances 0.000 claims abstract description 24
- 230000001070 adhesive effect Effects 0.000 claims abstract description 24
- 239000000203 mixture Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 13
- -1 anthracene-protected cyanoacrylate Chemical class 0.000 claims description 12
- 238000004132 cross linking Methods 0.000 claims description 9
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000004014 plasticizer Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 239000003381 stabilizer Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 4
- 229940095066 hydroxytyrosol Drugs 0.000 claims description 4
- 235000003248 hydroxytyrosol Nutrition 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 238000007334 copolymerization reaction Methods 0.000 claims description 3
- 238000010511 deprotection reaction Methods 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 230000023597 hemostasis Effects 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 239000012779 reinforcing material Substances 0.000 claims description 3
- 210000004872 soft tissue Anatomy 0.000 claims description 3
- 230000009278 visceral effect Effects 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 abstract description 15
- 229920001651 Cyanoacrylate Polymers 0.000 abstract description 12
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 abstract description 9
- 239000000047 product Substances 0.000 description 23
- 238000012360 testing method Methods 0.000 description 18
- 238000002386 leaching Methods 0.000 description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000008354 sodium chloride injection Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 239000004830 Super Glue Substances 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 238000012925 biological evaluation Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000001724 microfibril Anatomy 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 231100000263 cytotoxicity test Toxicity 0.000 description 3
- JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 3
- 229950010048 enbucrilate Drugs 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 206010070835 Skin sensitisation Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 231100000370 skin sensitisation Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000001069 triethyl citrate Substances 0.000 description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 2
- 235000013769 triethyl citrate Nutrition 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000899 acute systemic toxicity Toxicity 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000005360 alkyl sulfoxide group Chemical group 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229910000410 antimony oxide Inorganic materials 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- NKKMVIVFRUYPLQ-UHFFFAOYSA-N but-2-enenitrile Chemical compound CC=CC#N NKKMVIVFRUYPLQ-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 229960002242 chlorocresol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical group C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- RXJJVYBGRFLCOX-UHFFFAOYSA-N dioctyl pentanedioate Chemical compound CCCCCCCCOC(=O)CCCC(=O)OCCCCCCCC RXJJVYBGRFLCOX-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- VTRUBDSFZJNXHI-UHFFFAOYSA-N oxoantimony Chemical compound [Sb]=O VTRUBDSFZJNXHI-UHFFFAOYSA-N 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Chemical group 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920002721 polycyanoacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000004537 potential cytotoxicity Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008053 sultones Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000005951 type IV hypersensitivity Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
- C08F20/42—Nitriles
- C08F20/50—Nitriles containing four or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J4/00—Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
The invention relates to the field of materials, and particularly provides a material monomer and a preparation method and application thereof. The invention provides a cyanoacrylate material monomer containing a catechol functional group, which can increase the adhesive force and underwater adhesive ability of cyanoacrylate materials through the catechol functional group of a side chain.
Description
Technical Field
The invention relates to the field of materials, in particular to a material monomer and a preparation method and application thereof.
Background
Cyanoacrylate adhesives are monomeric adhesives that polymerize by free radical and anionic polymerization reactions based on esters of alpha-cyanoacrylate. Therefore, cyanoacrylate adhesives undergo rapid polymerization curing in an environment containing a slight amount of water, resulting in a failure in adhesive ability. Meanwhile, cyanoacrylate adhesives have poor underwater adhesion and are not water-resistant. Therefore, the improvement of the wet bonding capability of the cyanoacrylate adhesive is of great significance to the expansion of the application field of the products.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
The first purpose of the invention is to provide a material monomer.
The second purpose of the invention is to provide a preparation method of the material monomer.
A third object of the present invention is to provide a composition.
A fourth object of the invention is to provide the use of a material monomer or composition.
A fifth object of the present invention is to provide a polymer.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
a material monomer has the following structural formula:
the preparation method of the material monomer comprises the steps of carrying out esterification reaction on anthracene-protected cyanoacrylate and hydroxytyrosol, and carrying out deprotection group reaction to obtain the material monomer.
A composition comprising the monomer of material described above.
Further, the composition further comprises an adjuvant.
Further, the adjuvants are selected from thickeners, stabilizers, thermal and/or photo initiators and accelerators to initiate crosslinking, colorants, plasticizers, preservatives, heat sinks, fibrous reinforcing materials.
Use of a monomer or composition of the above material in the preparation of an adhesive.
Further, the adhesive includes an adhesive for use in underwater or wet environments;
preferably, the adhesive comprises a medical adhesive including adhesives for wound adhesion, hemostasis, visceral and soft tissue wound closure, coverage, leakage occlusion, hard tissue fixation.
Further, the material to be bonded is wood, metal, ceramic, plastic or a material consisting of a mixture of the above materials.
Further, the material has water in any physical state on its surface.
A polymer obtained by crosslinking copolymerization of the above material monomer or composition under the action of anion.
Compared with the prior art, the invention has the beneficial effects that:
the invention provides a cyanoacrylate material monomer containing catechol functional groups, wherein two phenolic hydroxyl groups of catechol can form strong hydrogen bonds and compete with water to obtain hydrogen bond points, and the hydrogen bond action is favorable for polar and hydrophilic surface adsorption, and in addition, chelate and non-covalent bonds can be formed; secondly, the chemical versatility of the catechol functional group can also realize adhesion, crosslinking and solidification through different chemical reactions, the catechol can be oxidized into quinone under certain conditions, and the oxidized quinone can be rearranged and dehydrogenated to further form crosslinking. Not only can react with amino and sulfydryl through Michael addition and Schiff base, but also can form dehydroindole carboxylate through intramolecular cyclization, and finally forms crosslinking. And simultaneously, the disproportionation reaction can be carried out to form free radicals which are coupled into tannin compounds. Therefore, the adhesive force and underwater adhesive capacity of the cyanoacrylate materials can be increased through the catechol functional group of the side chain.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer.
Unless otherwise defined, technical and scientific terms used herein have the same meaning as is familiar to those skilled in the art. In addition, any methods or materials similar or equivalent to those described herein can also be used in the present invention.
The invention provides a material monomer, which has the following structural formula:
the material monomer is formed by bonding a catechol group (3, 4-dihydroxyphenylalanine) to a cyanoacrylate material by a chemical bonding mode so as to improve the wet bonding capability of the cyanoacrylate material.
The preparation method of the material monomer comprises the following steps of carrying out esterification reaction on anthracene-protected cyanoacrylate and hydroxytyrosol, and carrying out deprotection group reaction to obtain the material monomer.
In a preferred embodiment, the material monomers are synthesized as follows:
the synthetic route is simple and easy to operate, and the cost is low.
The invention provides a composition containing the material monomer. In addition, other adjuvants may be present, such as thickeners, stabilizers, thermal and/or photo initiators and accelerators to initiate crosslinking, colorants, plasticizers, preservatives, heat sinks, fiber reinforcements, and the like.
In a preferred embodiment, the thickener comprises polycyanoacrylate, polylactic acid, polyglycolic acid, polycaprolactone, polyalkylacrylate, polyalkylmethacrylate; the stabilizer comprises an anionic stabilizer and a free radical stabilizer, wherein the anionic stabilizer comprises metaphosphoric acid, maleic anhydride, alkyl sulfonic acid, phosphorus pentoxide, ferric chloride (III), antimony oxide, 2,4, 6-trinitrophenol, mercaptan, alkyl sulfonyl, alkyl sulfone, alkyl sulfoxide, alkyl sulfite, sultone, sulfur dioxide and sulfur trioxide; the latter are hydroquinone, catechol and derivatives of the above compounds; initiators or accelerators include: molecules with nucleophilic function, organic or inorganic or their mixture, selected from amino, quaternary amine, hydroxyl, thiol, phosphorus-containing compound, preferably NaHCO3,Na2CO3Or sodium phosphate; the colorant is selected from dyes, pigments, including PGA microfibrils, collagen microfibrils, cellulose microfibrils and olefinic microfibrils; the plasticizer comprises polyethylene glycol ester, butyl stearate, lauric acid, dioctyl glutarate, and glycerolOil triesters, dioctyl acetate, triethyl phosphate, triethyl citrate, acetyl tributyl citrate; preservatives include those conventionally used but which do not initiate polymerization of the monomers and are selected from potassium sorbate, sodium benzoate, sorbic acid, chlorocresol; the heat sink comprises a liquid miscible with the monomer that evaporates during polymerization, releasing heat from the composition; the fibrous reinforcing material comprises natural or synthetic rubber to enhance the impact resistance of the composition, preferably styrene or acrylonitrile.
The material monomer or the composition provided by the invention can be used as an adhesive, and is particularly suitable for an aqueous medium (namely a solution under water, wherein the water can be pure water, fresh water, salt water, seawater, ocean water, polluted water and water which is considered as a main solvent in a general case) or under a humid condition, and the material to be bonded can be wood, metal, ceramic, plastic or a material composed of a mixture of the materials. In addition, the material monomer or composition can also be used in medical applications, such as medical adhesives, for wound adhesion, hemostasis, visceral and soft tissue wound closure, covering, leakage stoppage, hard tissue fixation, and the like.
The invention finally provides a polymer obtained by crosslinking copolymerization of the above monomers or compositions of materials under the action of anions.
The invention is further illustrated by the following specific examples, which, however, are to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
EXAMPLE 1 preparation of monomer of Material
The synthetic route is as follows:
the specific operation is as follows:
(1) 300g of anthracene and 1000mL of toluene were charged in a 3000mL three-necked flask, and SO was introduced while stirring2Gas 2h, 200g of cyanopropene were added dropwiseHeating ethyl acetate to 120 ℃, refluxing for 48h, cooling to room temperature, distilling toluene by a water pump under reduced pressure, adding 1000mL of ethanol, heating at 100 ℃, refluxing, stirring for 40 min, cooling to room temperature, and crystallizing at-20 ℃. And (4) performing suction filtration to obtain 390g of white crystalline solid-ethyl anthracenylcyanoacrylate. The yield was about 80%.
(2) 150g of anthracene cyanoacrylate and 500mL of ethanol are added into a 2000mL three-necked flask, the temperature is raised to 40 ℃, 200mL of 4.5mol/L KOH aqueous solution is added dropwise, after reaction is carried out for 3 hours, 500mL of water is added, stirring is carried out for 20min, insoluble matters are filtered off, filtrate is collected and is adjusted to pH 2 by 6mol/L hydrochloric acid, filtration is carried out, a filter cake is washed by a large amount of distilled water until the pH is about 5.5, and vacuum drying is carried out, so that 110g of white solid-anthracene cyanoacrylate is obtained, and the yield is about 90%.
(3) 21g of anthracyanoacrylate, 3g of DMAP and 300mL of dichloromethane are added into a 500mL round-bottom flask, the mixture is stirred until the reaction solution becomes clear, 4g of hydroxytyrosol is added, the stirring is continued for 10 minutes, and 20g of DCC is added. After stirring overnight at room temperature the reaction was monitored by TLC, filtered and concentrated, petroleum ether: ethyl acetate 5: 1 column chromatography to obtain colorless solid (3, 4-dihydroxy phenethyl (12S) -12-isocyano-9, 10-dihydro-9, 10-ethyl anthracene-12-carboxylate) 8.5 g. 80% yield.
(4) Weighing 4g of the product obtained in the step (3), 2.8g of maleic anhydride, a small amount of phosphorus pentoxide, hydroquinone and 50mL of xylene, carrying out reflux reaction at 160 ℃ for 6h, stopping the reaction, distilling off the xylene under reduced pressure, and reacting the xylene with acetone: diethyl ether 1: 3 at-20 ℃ to give 1.1g of a pale yellow oil (3, 4-dihydroxyphenethyl-2-isocyanoacrylate). 50% yield.
Example 2 shear tensile Strength
Shear tensile strength is a common indicator of adhesive bonding ability. The national pharmaceutical industry standard (YY/T0729-2009) is taken as the experimental guidance. Long strips of pigskin (2.5 cm. times.10 cm) were prepared and tested in a dry environment and a wet environment with water, respectively. And (3) drying environment: sucking 20. mu.L of monomer and dropping the monomer on 2.5X 1cm of pigskin2Quickly coating the area with the same size, quickly lapping another pigskin with the same size on the area, pressing for 10min with 10N vertical direction, and testing the fracture of the bonding area of the two pigskins at constant speed of 20mm/min by using a tensile testing machineThe shear tensile strength was calculated. The environment is wet by water: firstly, 200 mu L of distilled water is sucked and smeared on the pigskin with the thickness of 2.5 multiplied by 1cm2The test was carried out after sucking 20. mu.L of the monomer material again to coat the adhesive region. The test results are shown below.
Example 3 combination formulation
By adding the thickening agent of poly n-butyl cyanoacrylate and the plasticizer of triethyl citrate, the whole colloid is relatively viscous, can be bonded under water or a humid environment better, and can not be diffused when being dropped into water. (n-butyl cyanoacrylate quickly diffuses and solidifies into a film on the water surface when being dripped into water) in the following material monomers: thickening agent: the plasticizer is (60-80): (5-30): 5-30), and preferably is a material monomer: thickening agent: plasticizer 60:20: 20.
Example 4 curing time
20 μ L of the monomer was applied uniformly to 4 × 4cm pigskin and allowed to change phase from liquid to solid within 3 minutes after contacting the pigskin tissue. The polymerization speed of the material is greatly reduced compared with that of the traditional n-butyl cyanoacrylate adhesive (within 30 s), probably because the steric hindrance of catechol chains in monomer molecules and the polymerization inhibition of phenolic hydroxyl groups influence the thermodynamic collision efficiency of olefinic double bonds, and the complete curing time is prolonged.
Example 5 evaluation of biological safety
Cytotoxicity
Part 5 of the biological evaluation of medical devices according to GB/T16886.5-2017: the in vitro cytotoxicity test method adopts sterile normal saline injection and sterile normal saline injection with the volume fraction of 2 percent DMSO as leaching liquor to carry out MTT method test. The product is taken out and added into a 6-hole plate under aseptic condition,applying 10 μ L of the extract to each well, and adding 5% CO2After 2 days of curing in a 37 ℃ incubator. According to 6cm2The leaching solution is added in the ratio of/mL, and leached for 72 hours at 37 ℃ under the condition of shaking at 100 rpm. The cells were diluted to 25%, 12.5%, 6.25%, and 3.125% with serum-containing MEM medium before being contacted, while blank, negative, and positive controls were set. NCTCL929 cells in a logarithmic growth phase are selected for the test, the appearance of the cells is observed after the sample is contacted with the cells for 24 hours, and the survival rate of the cells is determined by an MTT method.
Experimental materials and instruments: the kit comprises the product, MEM culture medium, fetal calf serum, penicillin, streptomycin, normal saline, DMSO, a carbon dioxide incubator, NCTC L929 mouse fibroblast, pancreatin, a 96-well culture plate, a microscope (Olympus model: IX71), MTT, isopropanol, a mixing machine (eppendort, model: MIXMATE) and an enzyme labeling machine (Thermo SCIENTIFIC, model: MIXMATE).
TABLE 1 in vitro cytotoxicity test morphology observations
TABLE 2 polar leach liquor group in vitro cytotoxicity test MTT test results
TABLE 3 MTT test results of in vitro cytotoxicity experiments of nonpolar leach liquor components
Note: the absorbance values were OD570nm-OD650 nm.
The experimental results are as follows: the cell morphology shown in tables 1, 2 and 3 shows that discrete particles exist in cytoplasm of the non-polar leach liquor and the polar leach liquor cultured cells of each concentration of the product, no cells are dissolved, and no cell proliferation is reduced. The cell survival rate of 25% of the non-polar leaching solution of the product is 97% and the cell survival rate of 25% of the polar leaching solution is 92% through MTT method detection. The product, namely 25 percent of non-polar leaching liquor and 25 percent of polar leaching liquor, has no potential cytotoxicity reaction.
Sensitization
Part 10 of the biological evaluation of medical devices according to GB/T16886.10-2005: and in the stimulation and delayed hypersensitivity tests, 0.9 percent sodium chloride injection (one group) and fresh vegetable oil (two groups) are selected as leaching liquor, 0.1mL is injected into each injection point in an intradermal way, and the skin condition of the animal excitation part is observed and recorded after 24 hours and 48 hours of excitation.
Experimental materials and instruments: guinea pig, Freund's adjuvant (SIGMA F5881-10ml CAS9007-81-2), 0.9% sodium chloride injection, cotton seed oil, syringe, the product.
The experimental results are as follows:
TABLE 4 skin sensitization test
The experimental results are shown in the table, and the product has no skin sensitization reaction.
Intradermal reaction
Part 10 of the biological evaluation of medical devices according to GB/T16886.10-2005: stimulation and delayed hypersensitivity tests.
Experimental materials and instruments: healthy rabbits, syringes, 0.9% sodium chloride injection, cottonseed oil and the product.
TABLE 5 intradermal stimulation test
The experimental results are as follows: as shown in Table 5, after the injection of the leaching liquor of the product, the difference between the average scores of the product group and the control group is less than 1.0, and the product has no skin irritation.
Skin irritation
The experimental purposes and methods: the product is tested for skin irritation. Part 10 of the biological evaluation of medical devices according to GB/T16886.10-2005: stimulation and delayed type hypersensitivity tests, the skin condition of the application site was observed at 1, 24, 48 and 72 hours after 0.1mL of the product was applied to the skin of rabbits at home and blocked for 4 hours.
Experimental materials and instruments: rabbit, the product, depilatory, pipettor, medical gauze.
TABLE 6 acute skin irritation test results of this product for rabbits
The experimental results are as follows: as shown in Table 6, the skin of the experimental area does not have any erythema and/or edema symptoms, and the product has no irritation on the skin of the rabbits.
Acute systemic toxicity
Purpose of the experiment: the acute toxicity of the product is respectively evaluated by adopting the modes of direct polymer gavage and leaching liquor injection.
(1) The experimental method comprises the following steps: according to GB/T-14233.2-2005, 10g/kg of biodegradable medical gel polymer is administrated by intragastric administration to mice.
The experimental results are as follows: after the mice are subjected to gastric lavage, no toxic reaction occurs, the mice are killed and examined for diseases after 4 days, and no abnormality is observed by naked eyes.
(2) The experimental method comprises the following steps: the polymer colloid leaching liquor (leaching ratio is 1.25 cm)2mL, the leaching medium is sterile physiological saline) are respectively injected into tail vein and abdominal cavity, and the dosage is 50 mL/kg.
Experimental materials and instruments: 2% methylcellulose solution, product, Kunming mouse, model JA1003 electronic balance (Shanghai Yueping scientific instruments Co., Ltd.).
The experimental results are as follows: no significant toxicity was observed, mice did not show special toxicant symptoms, no death, and normal weight gain, similar to normal controls.
The experiments indicate that no acute toxicity of mice is observed under the experimental conditions of the product.
Hemolysis of blood
The experimental method is carried out according to GB/T14233.2-2005, GB/T16886.12-2017. Healthy adult rabbits with the body weight of more than 2.0kg are selected, blood is collected from the heart on the test day, and diluted anticoagulated rabbit blood is prepared after anticoagulation. The test sample contained 5% CO2Curing the mixture in a constant-temperature incubator at 37 ℃ for 2d, adding 0.9% sodium chloride injection, leaching for 72h at 37 ℃, and respectively collecting 10mL of leaching liquor to test sample tubes; adding 10mL of 0.9% sodium chloride injection into each tube of the negative control group; the positive control group added 10mL of purified water per tube. Each set operated 3 tubes in parallel. And (3) after the temperature is kept for 30min, 0.2mL of diluted anticoagulated rabbit blood is added into each test tube, and the temperature is kept for 60min after the mixture is uniformly mixed. After the liquid in the tube was poured out, it was centrifuged, and absorbance was measured at a wavelength of 545nm with an ultraviolet spectrophotometer, and the hemolysis ratio (%) of the test sample was calculated.
Experimental materials and instruments: adult rabbit, anticoagulant, 0.9% sodium chloride injection, the product, a constant temperature water bath kettle and an ultraviolet spectrophotometer.
The experimental results are as follows: the product has the hemolysis rate of 0.2 percent under the above experimental conditions, has no obvious hemolysis risk and conforms to the GB/T14233.2-2005 standard.
The invention synthesizes the cyanoacrylate material monomer containing catechol functional group by a chemical synthesis mode. The monomer is liquid at normal temperature, and can be polymerized under the condition of anion due to containing cyanoacrylate functional group. And because it contains catechol functional group, it can maintain the adhesive ability in wet environment, and improve the wet adhesive ability without reducing the original adhesive ability of cyanoacrylate material.
While particular embodiments of the present invention have been illustrated and described, it would be obvious that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (10)
2. the method for preparing the material monomer according to claim 1, wherein the material monomer is obtained by esterification of anthracene-protected cyanoacrylate with hydroxytyrosol followed by deprotection group reaction.
3. A composition comprising the material monomer of claim 1.
4. The composition of claim 3, wherein the composition further comprises an adjuvant.
5. Composition according to claim 4, characterized in that the adjuvants are chosen from thickeners, stabilizers, thermal and/or photo initiators and accelerators to initiate crosslinking, colorants, plasticizers, preservatives, heat-dissipating agents, fibrous reinforcing materials.
6. Use of a material monomer according to claim 1 or a composition according to any one of claims 3 to 5 in the preparation of an adhesive.
7. Use according to claim 6, wherein the adhesive comprises an adhesive for underwater or humid environments;
preferably, the adhesive comprises a medical adhesive including adhesives for wound adhesion, hemostasis, visceral and soft tissue wound closure, coverage, leakage occlusion, hard tissue fixation.
8. Use according to claim 7, characterized in that the material to be bonded is wood, metal, ceramic, plastic or a material consisting of a mixture of the aforementioned materials.
9. Use according to claim 8, wherein the material has water in any physical state on its surface.
10. A polymer obtained by anionic cross-linking copolymerization of a monomer according to claim 1 or a composition according to any one of claims 3 to 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111245015.0A CN113816875A (en) | 2021-10-26 | 2021-10-26 | Material monomer and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111245015.0A CN113816875A (en) | 2021-10-26 | 2021-10-26 | Material monomer and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113816875A true CN113816875A (en) | 2021-12-21 |
Family
ID=78917390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111245015.0A Pending CN113816875A (en) | 2021-10-26 | 2021-10-26 | Material monomer and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113816875A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5063243A (en) * | 1988-04-28 | 1991-11-05 | Suntory, Ltd. | Derivative of caffeic acid and pharmaceutical composition containing the same |
CN103083718A (en) * | 2011-11-02 | 2013-05-08 | 中国人民解放军军事医学科学院毒物药物研究所 | Biodegradable medical adhesive, and preparation method and purpose thereof |
CN104619797A (en) * | 2012-05-23 | 2015-05-13 | 汉高股份有限及两合公司 | A curable composition comprising cyanoacrylate monomers |
-
2021
- 2021-10-26 CN CN202111245015.0A patent/CN113816875A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5063243A (en) * | 1988-04-28 | 1991-11-05 | Suntory, Ltd. | Derivative of caffeic acid and pharmaceutical composition containing the same |
CN103083718A (en) * | 2011-11-02 | 2013-05-08 | 中国人民解放军军事医学科学院毒物药物研究所 | Biodegradable medical adhesive, and preparation method and purpose thereof |
CN104619797A (en) * | 2012-05-23 | 2015-05-13 | 汉高股份有限及两合公司 | A curable composition comprising cyanoacrylate monomers |
Non-Patent Citations (1)
Title |
---|
ALFONSO BENTOLILA等: "Fluorescent Cyanoacrylate Monomers and Polymers for Fingermark Development", 《MACROMOLECULES》, vol. 46, pages 4822 - 4828 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6334405B2 (en) | Biodegradable medical adhesive, its preparation and use | |
US3722599A (en) | Fluorocyanoacrylates | |
EP3974462A1 (en) | Polyethylene glycol derivative, preparation method therefor, and polyethylene glycol hydrogel enabling fast crosslinking reaction | |
US5320886A (en) | Hydrophilic crosslinking monomers and polymers made therefrom | |
CN113372494B (en) | Anticoagulant polymer coating material and preparation method thereof | |
US9428532B2 (en) | Methods for making biocompatible polymerizable acrylate products | |
WO2013024815A2 (en) | Block copolymer, and antithrombotic coating agent | |
JP6393324B2 (en) | Polymerizable monomer containing 1,3,5-triacryloyl-hexahydro-1,3,5-triazine moiety, process for producing them, and dental composition containing them | |
CN106866883B (en) | A method of the double Biomimetic Polymers of synthesis are reacted with amino based on aldehyde radical | |
JPS5930877A (en) | Adhesive | |
CN113816875A (en) | Material monomer and preparation method and application thereof | |
CN113861073A (en) | Material monomer OGAN-CA, and preparation method and application thereof | |
JP2008194363A (en) | Antithrombogenic coating agent and medical tool | |
US2599564A (en) | Esters of polygalacturonic acid methylglycoside and salts thereof | |
RU2607519C1 (en) | Partial gold salt of polyacrylic acid, method for production thereof and agent based thereon, having haemostatic action when used externally | |
US4215106A (en) | Local hemostatic | |
US4468378A (en) | Oxysulfonic derivative of copolymer of acrolein and acrylic acid and direct action anticoagulant on its basis | |
JP3799374B2 (en) | Adhesive composition | |
JP2753617B2 (en) | Antithrombotic material | |
JP2008194362A (en) | Antithrombogenic coating agent and medical tool | |
CN108498536B (en) | The purposes of sulfated heparin disaccharides grafting polymethyl acyl ethanol amine | |
JP3108453B2 (en) | Anticoagulant materials and medical devices | |
DE1070828B (en) | Process for the preparation of polymeric quaternary ammonium compounds | |
JPS6168454A (en) | Preparation of n-2-hydroxyethylacrylamide or n-2-hydroxyethylmethacrylamide | |
RU2034851C1 (en) | Method of preparing of biologically active chitosan ether sulfate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230530 Address after: 101400 No. 536, Huaisha Road, Bohai Town, Huairou District, Beijing (cluster registration) Applicant after: Beijing ruigu Technology Development Co.,Ltd. Applicant after: Beijing Jinsheng Xingyi Technology Development Co.,Ltd. Address before: 101400 No. 536, Huaisha Road, Bohai Town, Huairou District, Beijing (cluster registration) Applicant before: Beijing ruigu Technology Development Co.,Ltd. |